DavidEKandzariMD
Cardiology • Atlanta, GAAdult Congenital Heart Disease, Interventional Cardiology
Physician
Dr. Kandzari is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
95 Collier Road, Nw
Suite 2065
Atlanta, GA 30309Phone+1 404-605-2800Fax+1 404-720-0911- Is this information wrong?
Education & Training
Duke University HospitalFellowship, Cardiovascular Disease, 1998 - 2002
Johns Hopkins UniversityResidency, Internal Medicine, 1995 - 1998
Duke University School of MedicineClass of 1995
Certifications & Licensure
CA State Medical License 2008 - Present
GA State Medical License 2010 - 2026
TX State Medical License 2008 - 2011
NC State Medical License 1999 - 2008
VA State Medical License 2004 - 2006- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2012-2014
- Atlanta Magazine: Top Doctors Castle Connolly, 2011-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Join now to see all
Clinical Trials
- Evaluation of the Metricath Gemini System, a Device Intended to Make Arterial Measurements and Perform Angioplasty Dilations. Start of enrollment: 2005 Nov 01
- Study to Evaluate the Effect of Simvastatin, Losartan and Pioglitazone on Patients With Peripheral Arterial Disease. Start of enrollment: 2005 Dec 01
- CYPRESS - CYPHER for Evaluating Sustained Safety Start of enrollment: 2009 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- A novel, proof-of-concept radiofrequency renal denervation strategy to improve procedural efficiency: 12-month results from the SPYRAL DYSTAL pilot study.Andrew S P Sharp, Raymond R Townsend, Kazuomi Kario, Felix Mahfoud, Roland E Schmieder, Konstantinos Tsioufis, Michael Böhm, Minglei Liu, Vanessa DeBruin, David E Kand...> ;Cardiovascular Revascularization Medicine. 2024 Apr 10
- Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results from the TARGET BP I Randomized Clinica...Atul Pathak, James P Zidar, Manish Saxena, Roland E Schmieder, Adam J Janas, Christoph Langer, Alexandre Persu, Koen Ameloot, Malcolm Foster Iii, Helen Parise, Felix M...> ;Circulation. 2024 Apr 8
- 1 citationsIncidence, Predictors, and Impact of Hospital Readmission After Revascularization for Left Main Coronary Disease.Ioanna Kosmidou, Bahira Shahim, Ovidiu Dressler, Björn Redfors, Marie-Claude Morice, John D Puskas, David E Kandzari, Dimitri Karmpaliotis, W Morris Brown 3rd, Nichola...> ;Journal of the American College of Cardiology. 2024 Mar 19
- Join now to see all
Journal Articles
- Original Investigations Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting Stents: BIOFLOW V 2-Year ResultsDavid E Kandzari, Ron Waksman, Donald E Cutlip, Elie G Gharib, ScienceDirect
- Original Investigation Left Main Revascularization with PCI or CABG in Patients with Chronic Kidney Disease: EXCEL TrialJohn D Puskas, David E Kandzari, Gennaro Giustino, Roxana Mehran, Martin B Leon, Philippe Genereux, Michael 3rd Ragosta, Charles A Simonton, Irving L Kron, Gregg W Stone, ScienceDirect
- Focus on Left Main Interventions Outcomes After Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting According to Lesion Site: Results f...Gregg W Stone, David E Kandzari, Nicholas J Lembo, ScienceDirect
- Join now to see all
Lectures
- Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization 3-Year Outcomes from the ...Society for Cardiovascular Angiography and Interventions, Phoenix, Arizona - 1/19/2013
- The Target BP Program: Ongoing and Future StudiesCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
- Some Stents Are More Equal Than Others (e.g., Ultra-Thin)!CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
- Join now to see all
Authored Content
- Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization 3-Year Outcomes from the Randomized BIOFLOW V TrialJune 2020
- Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization 3-Year Outcomes from the Randomized BIOFLOW V TrialJune 2020
- The Day After a Primary EndpointMarch 2018
- New-Onset Atrial Fibrillation After PCI or CABG for Left Main DiseaseFebruary 2018
- New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease the EXCEL TrialFebruary 2018
- New-Onset Atrial Fibrillation After PCI or CABG for Left Main DiseaseFebruary 2018
- New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease the EXCEL TrialFebruary 2018
- Join now to see all
Press Mentions
Renal Denervation in Black Patients: SYMPLICITY HTN 3 Reassures at 36 MonthsFebruary 28th, 2023- Reduction in BP Drives Treatment Preference for Hypertensive PatientsDecember 20th, 2022
- Feature | Science Highlights from AHA 2022December 2nd, 2022
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
Piedmont Atlanta HospitalAtlanta, Georgia- Union General HospitalBlairsville, Georgia
- Piedmont Eastside Medical CenterSnellville, Georgia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
